Higher rates of side effects lead to lower drug persistence of anti-TNF therapy among women with inflammatory bowel disease, according to study results.
Herma H. Fidder, of the department of gastroenterology and hepatology at University Medical Centre Utrecht, in the Netherlands, and colleagues wrote that patient-specific factors, like the ones they identified, can help physicians make important clinical decisions.
“Female sex has been associated with lower persistence of TNF alpha inhibitor therapy in psoriasis, psoriatic arthritis and rheumatoid arthritis,” they wrote. “In

Source link